ReviewMolecular neurobiology2025
Ubiquitination in the Nervous System: From Molecular Mechanisms to Disease Implications.
Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The ubiquitin‒proteasome system (UPS) comprises ubiquitin, various enzymes, and the proteasome, which are collectively responsible for selectively regulating protein degradation within the human body. Ubiquitination plays a crucial role in various physiological and pathological processes of the nervous system. In neurons, ubiquitination influences synaptic transmission, neural network formation, and mitochondrial homeostasis. E3 ubiquitin ligases (E3s) such as ubiquitin-protein ligase E3A (UBE3A), HUWE1, and Parkin, along with deubiquitinating enzymes (DUBs) such as USP9X (ubiquitin specific peptidase 9, X-linked) and OTUD5, are vital for neural development and functional maintenance. The dysregulation of ubiquitination is closely associated with neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD). A comprehensive understanding of the functions of ubiquitination in the nervous system and an in-depth exploration of its mechanisms in neural development and disease progression may reveal potential targets and therapeutic strategies for treating neurodegenerative disorders.
Indexed as
Identifiers
40663270What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.